BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26632845)

  • 1. Newly Constructed Network Models of Different WNT Signaling Cascades Applied to Breast Cancer Expression Data.
    Bayerlová M; Klemm F; Kramer F; Pukrop T; Beißbarth T; Bleckmann A
    PLoS One; 2015; 10(12):e0144014. PubMed ID: 26632845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis.
    Klemm F; Bleckmann A; Siam L; Chuang HN; Rietkötter E; Behme D; Schulz M; Schaffrinski M; Schindler S; Trümper L; Kramer F; Beissbarth T; Stadelmann C; Binder C; Pukrop T
    Carcinogenesis; 2011 Mar; 32(3):434-42. PubMed ID: 21173432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth.
    Matsuda Y; Schlange T; Oakeley EJ; Boulay A; Hynes NE
    Breast Cancer Res; 2009; 11(3):R32. PubMed ID: 19473496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/β-catenin signaling pathway and thioredoxin-interacting protein (TXNIP) mediate the "glucose sensor" mechanism in metastatic breast cancer-derived cells MDA-MB-231.
    Vaira S; Friday E; Scott K; Conrad S; Turturro F
    J Cell Physiol; 2012 Feb; 227(2):578-86. PubMed ID: 21448924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt signaling in triple negative breast cancer is associated with metastasis.
    Dey N; Barwick BG; Moreno CS; Ordanic-Kodani M; Chen Z; Oprea-Ilies G; Tang W; Catzavelos C; Kerstann KF; Sledge GW; Abramovitz M; Bouzyk M; De P; Leyland-Jones BR
    BMC Cancer; 2013 Nov; 13():537. PubMed ID: 24209998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
    Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
    Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological β-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma.
    Cheng Y; Cheung AK; Ko JM; Phoon YP; Chiu PM; Lo PH; Waterman ML; Lung ML
    BMC Cell Biol; 2013 Sep; 14():44. PubMed ID: 24073846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling.
    Prasad CP; Rath G; Mathur S; Bhatnagar D; Ralhan R
    Chem Biol Interact; 2009 Oct; 181(2):263-71. PubMed ID: 19573523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells.
    Bilir B; Kucuk O; Moreno CS
    J Transl Med; 2013 Nov; 11():280. PubMed ID: 24188694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of regulatory miRNAs of the Wnt/ β-catenin signaling pathway in tumorigenesis of breast cancer.
    Rahmani F; Tadayyon Tabrizi A; Hashemian P; Alijannejad S; Rahdar HA; Ferns GA; Hassanian SM; Shahidsales S; Avan A
    Gene; 2020 Sep; 754():144892. PubMed ID: 32534060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling network involved in the GPC3-induced inhibition of breast cancer progression: role of canonical Wnt pathway.
    Fernández D; Guereño M; Lago Huvelle MA; Cercato M; Peters MG
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2399-2418. PubMed ID: 30267212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt signaling pathway in invasive ductal carcinoma of the breast: relationship between beta-catenin, dishevelled and cyclin D1 expression.
    Prasad CP; Gupta SD; Rath G; Ralhan R
    Oncology; 2007; 73(1-2):112-7. PubMed ID: 18337623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deguelin inhibits growth of breast cancer cells by modulating the expression of key members of the Wnt signaling pathway.
    Murillo G; Peng X; Torres KE; Mehta RG
    Cancer Prev Res (Phila); 2009 Nov; 2(11):942-50. PubMed ID: 19861542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γ-Tocotrienol reversal of epithelial-to-mesenchymal transition in human breast cancer cells is associated with inhibition of canonical Wnt signalling.
    Ahmed RA; Alawin OA; Sylvester PW
    Cell Prolif; 2016 Aug; 49(4):460-70. PubMed ID: 27323693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canonical and non-canonical Wnt signaling are simultaneously activated by Wnts in colon cancer cells.
    Flores-Hernández E; Velázquez DM; Castañeda-Patlán MC; Fuentes-García G; Fonseca-Camarillo G; Yamamoto-Furusho JK; Romero-Avila MT; García-Sáinz JA; Robles-Flores M
    Cell Signal; 2020 Aug; 72():109636. PubMed ID: 32283254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.
    Prasad CP; Mirza S; Sharma G; Prashad R; DattaGupta S; Rath G; Ralhan R
    Life Sci; 2008 Aug; 83(9-10):318-25. PubMed ID: 18662704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells.
    Yuzugullu H; Benhaj K; Ozturk N; Senturk S; Celik E; Toylu A; Tasdemir N; Yilmaz M; Erdal E; Akcali KC; Atabey N; Ozturk M
    Mol Cancer; 2009 Oct; 8():90. PubMed ID: 19849855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The embryonic transcription cofactor LBH is a direct target of the Wnt signaling pathway in epithelial development and in aggressive basal subtype breast cancers.
    Rieger ME; Sims AH; Coats ER; Clarke RB; Briegel KJ
    Mol Cell Biol; 2010 Sep; 30(17):4267-79. PubMed ID: 20606007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
    Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.